Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...
Asıl Yazarlar: | Mukhtyar, C, Luqmani, R |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2007
|
Benzer Materyaller
-
Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
Yazar:: Mukhtyar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Eular recommendations for vasculitis
Yazar:: Luqmani, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Cardiovascular outcomes in ANCA associated vasculitis
Yazar:: Mukhtyar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
Yazar:: Mukhtyar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Cardiovascular involvement in primary systemic vasculitis.
Yazar:: Mukhtyar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)